1-phenyl-2-decanoylamino-3-morpholino-1-propanol has been researched along with thermozymocidin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Meredith, FI; Rentz, SS; Riley, RT; Showker, JL | 1 |
| Dijkhuis, AJ; Jacobs, S; Kamps, W; Klappe, K; Kok, JW; Kroesen, BJ; Sietsma, H | 1 |
| Bai, Y; Deng, J; Hao, H; Huang, Y; Li, S; Meng, L; Nan, D; Peng, Q; Shen, Z; Yu, W; Yu, Z | 1 |
3 other study(ies) available for 1-phenyl-2-decanoylamino-3-morpholino-1-propanol and thermozymocidin
| Article | Year |
|---|---|
Inhibition of sphingolipid biosynthesis decreases phosphorylated ERK2 in LLC-PK1 cells.
Topics: Acyltransferases; Animals; Apoptosis; Cell Division; Cycloserine; Enzyme Inhibitors; Fatty Acids, Monounsaturated; Fumonisins; Glucosyltransferases; LLC-PK1 Cells; Mitogen-Activated Protein Kinase 1; Morpholines; Oxidoreductases; Phosphorylation; Serine C-Palmitoyltransferase; Sphingolipids; Swine | 2005 |
PDMP sensitizes neuroblastoma to paclitaxel by inducing aberrant cell cycle progression leading to hyperploidy.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; CDC2 Protein Kinase; Cell Cycle; Ceramides; Cyclin-Dependent Kinase 2; Down-Regulation; Drug Resistance, Neoplasm; Fatty Acids, Monounsaturated; Lipid Metabolism; Mice; Morpholines; Neuroblastoma; Paclitaxel; Polyploidy; Sphingolipids | 2006 |
Myriocin and d-PDMP ameliorate atherosclerosis in ApoE-/- mice via reducing lipid uptake and vascular inflammation.
Topics: Animals; Anticholesteremic Agents; Apolipoproteins E; Atherosclerosis; Atorvastatin; Biological Transport; Ceramides; Fatty Acids, Monounsaturated; Glycosphingolipids; Immunosuppressive Agents; Lipid Metabolism; Lipids; Mice, Inbred C57BL; Mice, Knockout; Morpholines; Plaque, Atherosclerotic; Vasculitis | 2020 |